Q3 2025 Earnings Call November 11, 2025 10:30 AM ESTCompany ParticipantsRosana Avolio - Investor Relations ManagerRoberto Ramos - ...

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

The Tide's efficiency metrics looked slightly better than the eye test, but defensive dominance sealed the win ...

We look into the tightly-knit British bicycle trials scene and asks if Danny MacAskill helped nearly kill it off.